Cellular Life Solutions’ Post

We are pleased to support the 8th Update on Fabry Disease meeting where experts from the scientific and medical communities will join together to share the latest research and discuss important advances related to the management of #Fabry disease. Learn more: https://lnkd.in/eUtSTxyu   #RareDiseases #ChiesiGlobalRareDiseases

Begin your week with the latest Batten disease research and clinical news courtesy of Dr. Ineka Whiteman! Her August column covers MAJOR Batten disease clinical news, visits to Clinical Centers of Excellence, publication summaries, and more. 🔗 https://ow.ly/QLa650Tb2CX #BattenAdvocatesForACure #battendisease #battenresearch #research #clinicaltrial #raredisease

Published by Kidney International, this editorial for #WorldKidneyDay explores the importance of knowledge translation, early diagnosis and prevention in achieving equitable, evidence-based kidney care. According to the authors, "Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do." Read the full article here: https://lnkd.in/gx3Sdh7F

How can foundational research take therapies from the lab bench to the bedside? In this episode of AudioHelicase, learn how three Whitehead Institute researchers are driving breakthroughs in disease treatment. https://lnkd.in/gECj69iU

My first job in healthcare was in gastroenterology on 2 products Proton pump inhibitor and Prokinetic. So I’ve spend a lot of time with gastros, endoscopy doctors, many conferences and in many hospitals. The biggest indication market for both products was GERD (gastroesophagel reflux disease), which is considered very prevalent(10-20% of population). I remember clearly there were 2-3 key topics, one related to helycobacter eradication, and another one to refractory GERD. I can for sure tell that back in the days, EoE was never a topic, which makes me think- what is the true epidemiology of EoE, how many people really suffer from it, currently misdiagnosed with GERD. EoE prevalence in literature is considered 50/100000, rarer than some or rare diseases, just compare it with 10-20% for GERD… I Hope that in the nearest time, with more innovations coming for this field, more patient and hcp worldwide will know more about how to properly diagnose and treat this disease!

The concept of functional medicine is a personalized approach to improving the health of patients by working with their doctors to identify and treat the underlying causes of disease. 💡 Instead of focusing on a single symptom, functional medicine focuses on the whole person. This concept is ideal for modern medicine. 👌 #quoteoftheday #functionalmedicine

Understanding endometriosis as a full-body, chronic pain disease requires a multidisciplinary care strategy- this was a very educational and insightful session! #SWHRTalksEndometriosis

ICYMI: Our 2022-23 Year in Review is now online! From an innovative study that provides researchers and clinicians with a standardized method for collecting health data from individuals with depression to the deployment of new technology that uses retinal scans to help diagnose Alzheimer’s disease, this annual report demonstrates the impact of OBI's lab-to-life approach. [And don't miss never-before-seen video footage of key collaborators...] Read all about it at https://lnkd.in/gFGXYtdb.

I am excited to share my latest article published by the MedReport Foundation on an important topic that continues to affect many individuals worldwide: Long COVID. I explore the susceptibility factors, highlighting that individuals with a history of allergies, autoimmune diseases, anxiety, and other health conditions may be more prone to developing Long COVID. Furthermore, I discuss the current management strategies, which focus on a symptom-based approach and comprehensive clinical assessments. Read the full article here: https://lnkd.in/ewfnUkvA

Did you know that women are more likely than men to dismiss the warning signs of a heart attack? Even though heart disease is the leading cause of death globally among both genders, women tend to present more subtle symptoms than men and these symptoms have been wildly under-researched. What if there was a way to replace the time and people needed for a successful clinical trial with technology? Enter virtual twins for precision medicine. Learn how medical professionals are using virtual twins to move away from a “one size fits all” treatment approach to a level of precision never seen before: http://go.3ds.com/sLS